Abnormal chromosome 8 copy number in stage I to stage IV breast cancer studied by fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 108, Issue 1, 1999, Pages 1-5

  Mark, Hon Fong L ^a,b,c   Taylor, William ^b   Brown, Stephen ^a   Samy, Mangala ^a   Sun, Ci Lin ^a   Santoro, Kathleen ^a   Bland, Kirby I ^b,c  

^a Lifespan   (United States)

^b Department of Pathology ^*  (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER STAGING; CHROMOSOME 8; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TRISOMY;

ANEUPLOIDY; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; OBSERVER VARIATION; TRISOMY;

EID: 0344135585     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00112-5     Document Type: Article

References (15)

1. Afify A., Bland K.I., Mark H.F.L. Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer. Breast Cancer Res Treat. 38:1996;201-208.
2. Afify A, Mark HFL (in press): FISH assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast. Cancer Genet Cytogenet.
3. Mark HFL, Taylor W, Afify A, Riera D, Rausch M, Huth A (in press): Stage I and stage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using FISH. Pathobiology.
4. Bloom H.J.G., Richardson W.W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 11:1957;359-377.
5. Pinkel D., Strawne R., Gray J. Cytogenetic analysis using quantitative high sensitivity, fluorescence hybridization. Proc Nat Acad Sci USA. 83:1986;2934-2938.
6. Mark H.F.L. Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann Clinic Lab Sci. 24:1994;153-163.
7. Miranda R.N., Mark H.F.L., Medeiros L.J. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathol. 145:1994;1-6.
8. Mark H.F.L., Grollino M.G., Sulaiman R.A., Lathrop J.C. Fluorescent in situ hybridization (FISH) assessment of chromosome copy number in gestational trophoblastic disease. Ann Clin Lab Sci. 25:1995;291-296.
9. Mark H.F.L., Mills D., Kim E., Santoro K., Quddus M., Lathrop J.C. Fluorescent in situ hybridization assessment of chromosome copy number in buccal mucosal cells. Cytobios. 87:1996;117-126.
10. Mark H.F.L., Mills D., Santoro K., Quddus M., Lathrop J.C. Fluorescent in situ hybridization (FISH) analysis of cervical smears. a pilot study of 20 cases Ann Clin Lab Sci. 27:1997;224-229.
11. Mark H.F.L., Afify A., Taylor W., Santoro K., Lathrop J.C. A subset of gestational trophoblastic disease (GTD) characterized by abnormal chromosome 8 copy number detected by FISH? Cancer Genet Cytogenet. 96:1997;1-6.
12. Mark H.F.L., Huth A., Santoro K., Ferreira K., Barker B. Sequential flow cytometry and FISH for the study of formalin-fixed paraffin-embedded breast cancer tissues. Cancer Genet Cytogenet. 98:1997;1-5.
13. Mark H.F.L., Rehan J., Mark S., Santoro K., Zolnierz K. FISH analysis of single-cell trisomies for determination of clonality. Cancer Genet Cytogenet. 100:1997;1-5.
14. Kim S.Y., Lee J.S., Ro J.Y., Gay M.L., Hong W.K., Hittleman W.N. Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. mapping/genotype heterogeneity Am J Pathol. 142:1993;307-317.
15. Hopman A.H.N., Van Hooren E., Van de Kaa Vooijs C.A., Ramaekers F.C.S. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancer. Mod Pathol. 4:1991;503-513.